← SynDRA
EB-47
SynDRA canonical compound SYN1951464 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | PARP1 |
| Mechanism of action | PARP inhibitor |
All known targets
Mechanisms of action (all sources)
- PARP inhibitor
- PARP1 INHIBITOR
Cross-references
Synonyms
- EB 47
- 5'-Deoxy-5'-[4-[2-[(2,3-dihydro-1-oxo-1H-isoindol-4-yl)amino]-2-oxoethyl]-1-piperazinyl]-5'-oxoadenosine Dihydrochloride
- DTXSID40692822
- ZINC98052573
- NCGC00370771-01
- KB-76747
- FT-0667818
- 4-[1-(6-Amino-9H-purin-9-yl)-1-deoxy-
- A-D-ribofuranuronoyl]-N-(2,3-dihydro-1-oxo-1H-isoindol-4-yl)-1-piperazineacetamide Dihydrochloride
- 2-{4-[(2R,3R,4S,5S)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxyoxolane-2-carbonyl]piperazin-1-yl}-N-(1-oxo-2,3-dihydro-1H-isoindol-4-yl)acetamide (non-preferred name)
Look up EB-47 in the interactive SynDRA portal →